Mammoth Biosciences

Reading and writing the code of life

Brisbane, United States · Founded 2017 · $263.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$263.0M
Last Round
$150.0M Series DSep 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. The full record is or through the API.

About

Mammoth Biosciences develops ultracompact CRISPR systems for potential in vivo gene-editing therapies for genetic diseases. Founded by CRISPR researchers, the company applies its technology to therapeutics and molecular diagnostics, including its DETECTR platform for nucleic-acid detection. Mammoth advances its wholly owned pipeline while collaborating with pharmaceutical and biotechnology partners to expand the reach of its proprietary CRISPR platform.

Summary

Mammoth Biosciences is a Biotech company based in Brisbane, United States, founded in 2017. It has raised $263.0M in total across 4 rounds, most recently a $150.0M Series D round in Sep 2021. Investors include Redmile Group, Decheng Capital and Mayfield Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DSep 2021
$150.0M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mammoth Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/mammoth-biosciences"><img src="https://indexed.vc/api/badge/company/mammoth-biosciences" alt="Mammoth Biosciences on Indexed.vc" width="260" height="76" /></a>